BNET Industries
Market Cap:$813.9K
Last Fiscal Year Sales:$932.0K
- Public
- US
Dow Jones Description
Unfortunately, Immune Response isn't immune to market forces. Founded in 1986 and headquartered in Carlsbad, CA, The Immune Response Corporation (OTCBB: IMNR.OB) develops products to treat autoimmune and infectious diseases. The company focuses primarily on Remune and its sister drugs for the treatment of AIDS, which were developed by the founder and eradicator of polio, Jonas Salk. It also develops NeuroVax, currently in Phase II clinical trials for the treatment of multiple sclerosis. The company had 2005 revenue of about $44,000 and employs about 38 people. In August 2006, it received approval to expand Phase II trials of IR103 from Italy into France.
Number of Employees 23
Contact Information
5931 Darwin Ct
Carlsbad, California 92008-7302
(760) 431-7080
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Mel Perelman | Director |
| David P. Hochman | Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| James B. Glavin | Chairman of The Board of Directors |
| Robert E. Knowling | Board of Directors |
James B. Glavin has 38 years of experience in the health care pharmaceutical industry. He has been Chairman of the Board of Directors of Immune Response since May 1993, CEO from April 1987 to September 1994, President from October 1987 to September 1994, and Treasurer from April 1987 to May 1991. He was Chairman of the Board of Directors of Smith Laboratories, Inc., a medical products company, from September 1985 to May 1990 and Acting President and CEO from September 1985 to August 1989. During 1985 to 1987 Mr. Glavin was a Partner in CH Ventures. From 1981 to 1983, he was President and CEO of Genetics Systems Corporation and Chairman of the Board from 1983 to 1985. In addition to being Director and Chairman of Immune Response, he is currently a Director of Nektar Therapeutic Systems, Inc., formerly Inhale Therapeutic Systems, Inc., Meridian Fund, and Chairman of the Board of Avanir Pharmaceuticals.
| Organization | Position | Status |
|---|---|---|
| Orchestra Therapeutics, Inc. | Chairman of The Board of Directors | Current |
| Icogen Corporation | Board of Directors | Current |
| Meridian Fund, Inc. | Director | Current |
| Althea Technologies, Inc. | Director | Current |
| AVANIR Pharmaceuticals | Director | Current |
| Orchestra Therapeutics, Inc. | Chief Executive Officer | Former |
| Orchestra Therapeutics, Inc. | President | Former |
| C&H Ventures | Partner | Former |
| AVANIR Pharmaceuticals | Chairman of the Board | Former |
| Harvard Business School | M.B.A | Former |
| Harvard University | Degree In Economics | Former |
Dr. Perelman has served as a member of Immusol's Board of Directors since 1996. Dr. Perelman began his career in 1957 as an organic chemist and held a number of positions at Eli Lilly & Co. (Lilly), including serving as President of Lilly International. From 1986 until his retirement in 1993, Dr. Perelman served as Executive Vice President of Lilly and President of Lilly Research Laboratories. He was a member of the Lilly Board of Directors and its Executive Committee from 1976 to 1993. Dr. Perelman received a bachelor's degree in chemistry from Northwestern University and a Ph.D. in organic chemistry from Rice University. Currently, Dr. Perelman is a Director at Immune Response Corporation, a biotech company and Inhale Therapeutics Systems, Inc., a drug delivery system company.
| Organization | Position | Status |
|---|---|---|
| Immusol, Inc. | Member | Current |
| Orchestra Therapeutics, Inc. | Director | Current |
| Immusol, Inc. | Director | Current |
| Lilly Research Laboratories | Executive Vice President of Lilly | Former |
| Eli Lilly and Company | organic chemist | Former |
| Rice University | Ph.D. In Organic Chemistry | Former |
| Northwestern University | Bachelor's Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Telwares Communications, LLC | Chief Executive Officer, Board Member | Current |
| The Leadership Academy | CEO | Current |
| Ariba, Inc. | Lead Director | Current |
| Ameri Tech | chairman | Current |
| Heidrick & Struggles International, Inc. | Board of Directors | Current |
| Ariba, Inc. | Board of Directors | Current |
| Aprimo, Incorporated | Board of Directors | Current |
| Orchestra Therapeutics, Inc. | Board of Directors | Current |
| The Bartech Group | Board of Directors | Current |
| Vercuity | Board Member | Current |
| Telwares | CEO | Former |
| Vercuity | Chief Executive Officer | Former |
| Covad Communications Company | CEO | Former |
| NYC Leadership Academy | Chief Executive Officer | Former |
| Simdesk Technologies, Inc. | CEO | Former |
| Covad Communications Company | president | Former |
| US West Communications | Executive Vice President of Operations and Technologies | Former |
| US WEST, Inc. | vice president of Network Operations | Former |
| Ameri Tech | vice president of Network Operations | Former |
| Simdesk Technologies, Inc. | Chairman | Former |
| Covad Communications Company | chairman | Former |
| National Services Inc. | Chair | Former |
| Telwares | Board of Directors | Former |
| Northwestern University | MBA | Former |
| Wabash College | BA in theology | Former |
| Organization | Position | Status |
|---|---|---|
| Tpp | Senior Principal | Current |
| Battelle Memorial Institute | Current | |
| Citizens for NYC | Board of Directors | Current |
| Prescient Medical, Inc | Director | Current |
| Modigene Inc. | Board Member | Current |
| Sustainable Profitability Group, Inc. | Board of Directors | Current |
| Orchestra Therapeutics, Inc. | Member | Current |
| Spencer Trask & Co. | Vice President of New Business Development | Former |
| Spencer Trask Ventures, Inc. | Managing Director | Former |
| Health Dialog Services Corporation | Former | |
| Orchestra Therapeutics, Inc. | Board Member | Former |
| Princeton University | A.B. | Former |
| New York University | Public Service | Former |
Industry Transcripts by Seeking Alpha
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ARNA
-
Javelin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about JAV
-
Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ALXA
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Best Selling Drugs Will Soon be Biologics, But Not Owned by Biotechs 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


